SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GelTex Pharmaceuticals (GELX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Roader who wrote (50)2/6/1998 12:32:00 PM
From: NY0001   of 127
 
Does anyone have access to the CSFB report or any other research
on GELX? Could you post any of it, please?

I find it interesting that CSFB is also covering GELX. They also
cover RAISIO of Finland and just upgraded their targets on
that company. Raisio has developed a cholesterol-lowering food addititve
that J&J has licensed. These additives may eventually compete
with the Cholesterol-lowering pharmaceutical market that GELX is in.

Novartis recently signed a similar agreement with Forbes Medi-Tech (FMI.V)
so it appears that this whole area of cholesterol-lowering foods may
be accelerating and may impact the pharmaceutical side. Although,
I note that FMI is also pursuing a cholesterol-lowering pharmaceutical
as well as a food additive approach.

Does the CSFB report address any of these issues?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News